The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2020
Filed:
Nov. 16, 2017
Applicant:
Emory University, Atlanta, GA (US);
Inventors:
Jeff M. Sands, Atlanta, GA (US);
Mitsi A. Blount, Atlanta, GA (US);
Janet D. Klein, Decatur, GA (US);
Assignee:
Emory University, Atlanta, GA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 33/00 (2006.01); A61K 45/06 (2006.01); A61K 31/155 (2006.01); A61K 31/341 (2006.01); A61K 31/343 (2006.01); A61K 31/405 (2006.01); A61K 31/427 (2006.01); A61K 31/549 (2006.01); A61K 31/4365 (2006.01); A61K 31/4965 (2006.01); A61K 31/7056 (2006.01); A61K 31/7076 (2006.01);
U.S. Cl.
CPC ...
A61K 31/343 (2013.01); A61K 31/155 (2013.01); A61K 31/341 (2013.01); A61K 31/405 (2013.01); A61K 31/427 (2013.01); A61K 31/4365 (2013.01); A61K 31/4965 (2013.01); A61K 31/549 (2013.01); A61K 31/7056 (2013.01); A61K 31/7076 (2013.01); A61K 33/00 (2013.01); A61K 45/06 (2013.01);
Abstract
In certain embodiments, the disclosure relates to methods of treating or preventing nephrogenic diabetes insipidus comprising administering an effective amount of a AMPK activator to a subject in need thereof, wherein In certain embodiments, the AMPK activator is metformin or salt thereof. In certain embodiments, the subject has been diagnosed with nephrogenic diabetes insipidus.